5610 results
Refine Your Search
John Leonard
John P. Leonard, MD, is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and Senior Associate Dean for Innovation and …
Ashley
It started in September of , the start of this new journey in life called acute myeloid leukemia (AML). September 13th was the day that something need…
Victor
Our father Victor was diagnosed in at the age of with Burkitt lymphoma (BL). He was living in Los Angeles, California, at the time and had just got…
Edmund
U.S. veterans’ sacrifices can occur on the battlefield … or much later. Houseboys sprayed Agent Orange on weeds around the Quonset huts of Edm…
Ari Melnick
Dr. Melnick is a recognized leader in the fields of hematologic malignancies and cancer epigenetics.
Constantine Mitsiades
Constantine Mitsiades MD, PhD, is an Assistant Professor at Cancer Institute (DFCI), Harvard Medical School, an Associate member of the Broad Institu…
Jonathan Licht
Jonathan D. Licht, MD, is the Director of the University of Florida Health Cancer Institute, leading it to become the 72nd center in the country. Dr.
Daniel Lucas
Daniel Lucas uses microscopy to understand how blood cells are produced in the marrow of the bone and how leukemia inhibits this process. A native Spa…
Jeffrey Magee
Dr. Magee directs the pediatric leukemia and lymphoma program at Washington University School of Medicine and St. Louis Children’s Hospital. He receiv…
Ravindra Majeti
Dr. Majeti is Professor of Medicine, Chief of the Division of Hematology, and Member of the Institute for Stem Cell Biology and Regenerative Medicine …
Daniel Pollyea
Dr. Daniel Pollyea has received degrees from the University of Chicago Pritzker School of Medicine and Stanford University. He served as Chief Medical…
Rizwan Romee
Dr. Romee is a translational at Dana Farber Cancer Institute, Harvard Medical School. His research goals are to translate novel aspects of immunolog…
Kathleen Sakamoto
Dr. Kathleen Sakamoto is Professor of Pediatrics at Stanford University School of Medicine. She has been studying the causes of AML and developing new…
Michael Savona
Dr. Savona is the Head of Hematology, Cellular Therapy and Stem Cell Transplant, the Beverly and George Rawlings Director of Hematologic Malignancies …
Marc Seifert
Marc Seifert graduated in Biology at the University of Cologne and did his PhD at the Institute of Cell Biology (IFZ) at the University Hospital Essen…
Mala Shanmugam
I am a cancer biologist and Associate Professor in the Department of Hematology and Medical Oncology at the Winship Cancer Institute, Emory University…
Stephen Oh
Stephen Oh, MD, PhD is Associate Professor of Medicine in the Division of Hematology at Washington University School of Medicine. Dr. Oh’s clinical an…
Robert Orlowski
Dr. Robert Orlowski, the Principal Investigator of this proposal, serves as the Florence Maude Thomas Cancer Research Professor and Director of the My…
Stephen Nimer
Dr. Nimer has cared for patients with MDS, AML, multiple myeloma, and lymphoma for over three decades. This melding of clinical studies and care, with…
Grzegorz Nowakowski
Grzegorz (Greg) Nowakowski, M.D., is a consultant and a Professor of Oncology and Medicine, Division of Hematology at Mayo Clinic in Rochester,Minneso…
Developing novel therapeutic approaches for classical and variant hairy cell leukemia
In this proposal, we have combined clinical and research expertise in HCL across Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College…
Discovery of Aging-Driven Mechanisms Causing Clonal Hematopoiesis (CH) and its Progression to Hematological Malignancy
My research focuses on why and how risk of acute myeloid leukemia (AML) increases with aging. Studying naturally aged mouse models in combination with…
BRAF inhibition as an alternative to chemotherapy in the treatment strategy of hairy cell leukemia
Hairy cell leukemia (HCL) is very sensitive to chemotherapy, whose toxicity to the bone marrow and the immune system is however concerning. We have es…
Precision Medicine Inhibitor and Immunotherapy Approaches for High-Risk Childhood Leukemias
Dr Tasian’s scientific passion is successful development of precision medicine therapies for childhood leukemia. Her translational laboratory researc…
Pediatric AML PDX Models and Drug Testing-Gateway to Novel PedAL Trials
Pediatric AML is a disease with poor outcomes and a need for improved therapeutic options. Pediatric AML is characterized by diverse lesions that ofte…